Press Releases and Product Information April 20, 2022
advertisement
- Introducing a New Standard for Diabetes Care
- Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch
- The mysterious case of Viatris and the missing insulin label deepens
- Dexcom announces availability of G6 for Tricare members as formulary pharmacy benefit
- Surf’s up: Startup stoked as Chris Garabedian fund funnels cash into ultra-rapid insulin program